Neurodegeneration experts present latest advances, focus on young investigators
At the Southeastern Neurodegenerative Disease Conference, main focus was advancing careers of newest investigators.
At the Southeastern Neurodegenerative Disease Conference, main focus was advancing careers of newest investigators.
In Medical News Today, Dr. Michael Okun weighed in on Boston University study, and stressed the need for collecting and publishing more data on relationship of contact sports, concussion and PD risk.
Learn about Dr. Karen Hegland’s research on swallowing and upper airway disorders among patients with Parkinson’s.
UF-Northwestern research team reports pegboard test could provide objective marker of Parkinson’s motor symptom changes.
Scanner housed at UF’s Advanced Magnetic Resonance Imaging and Spectroscopy Facility will bolster research efforts across campus.
Dr. Michael Okun commented for HealthDay article about a new study looking into pollution’s impact on Parkinson’s diagnoses.
UF study finds evoked resonant neural activity could serve as potential marker to guide DBS for Parkinson’s disease.
University of Florida neurogeneticist Matthew Farrer contributed to the new Michael J. Fox Foundation Global Genetic PD Cohort.
Progranulin loss results in sex-dependent dysregulation of peripheral and central immune system in mice.
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.